首页   按字顺浏览 期刊浏览 卷期浏览 New condensation methods in the synthesis of bicyclic bisureas
New condensation methods in the synthesis of bicyclic bisureas

 

作者: Angelina N. Kravchenko,  

 

期刊: Mendeleev Communications  (RSC Available online 2000)
卷期: Volume 10, issue 1  

页码: 27-28

 

ISSN:0959-9436

 

年代: 2000

 

出版商: RSC

 

数据来源: RSC

 

摘要:

Mendeleev Communications Electronic Version, Issue 1, 2000 (pp. 1–42) New condensation methods in the synthesis of bicyclic bisureas Angelina N. Kravchenko,* Oleg V. Lebedev and Elena Yu. Maksareva N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 117913 Moscow, Russian Federation. Fax: +7 095 135 5328 DOI: 10.1070/MC2000v010n01ABEH001186 For the first time, synthetic approaches to bicyclic bisureas of the octane series bearing three alkyl substituents at nitrogen atoms have been developed.Bicyclic bisureas of the octane series, 2,4,6,8-tetraazabicyclo- [3.3.0]octane-3,7-diones (TABOD) are a new class of promising physiologically active substances.1 Calculations performed by the QSAR method demonstrated that N-alkylated TABOD with methyl and ethyl substituents are most promising.2 Published data concerning condensation methods for preparing TABOD indicate that changes in the position and number of substituents at nitrogen atoms creates some synthetic difficulties.Only mono-, di- and tetra-N-methyl(ethyl)-substituted TABOD (cis- and trans-) can be prepared by known synthetic methods. Tri-N-methyl(ethyl)- substituted TABOD derivatives were not described in the literature.For the first time, we examined the interaction of N-methyl- (ethyl)ureas with glyoxal at pH 4–5 using 1H NMR spectroscopy and TLC control. We found that it results in corresponding mono-N-alkyl-4,5-dihydroxyimidazolidin-2-ones 1, 2 (Scheme 1) which were further condensed with N,N'-dialkylureas 5, 6. The condensation of 1 with 5 or 6 results in 9 (yield 47–49%) or 10 (yield 40–42%), respectively, and the condensation of 2 with 5 or 6 gives 11 (yield 44–46%) or 12 (yield 37–39%), respectively. This synthetic approach (method A) allowed us to obtain the following tri-N-alkyl-substituted TABOD: 2,4,6-trimethyl- 2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione 9, 2,4-diethyl-6- methyl-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione 10, 2,4- dimethyl-6-ethyl-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7-dione 11 and 2,4,6-triethyl-2,4,6,8-tetraazabicyclo[3.3.0]octane-3,7- dione 12.To confirm the structure of the compounds obtained, an independent synthesis was performed. 1,3-Dimethyl(diethyl)-4,5-dihydroxyimidazolidin- 2-ones 3, 4 were synthesised according to published procedures.4,5 These compounds (Scheme 1) reacted with N-monomethyl(monoethyl)ureas 7, 8 to form 9–12 (method B).The reaction of 3 with 7 or 8 results in 9 (yield 32–35%) or 11 (yield 50–52%), respectively, and the reaction of 4 with 7 or 8 gives 10 (yield 60–61%) or 12 (yield 37–39%), respectively. Both of the above approaches can be used for the synthesis of target products 9–12. However, method A seems to be more suitable for the synthesis of 9 and 12, and method B is better for the synthesis of 10 and 11. In addition, known tetra-N-alkyl- TABOD 13, 14 (20–25%) were formed simultaneously as a result of the interaction of dimethyl- and diethylureas with glyoxal. The physico-chemical properties of tri- and tetra-alkyl-TABOD are very similar, and therefore column chromatography was used to separate individual compounds 9–12.Tri-N-alkyl-TABOD 9–12 are of both theoretical and practical interest. This is evident not only from the structure of 9–12, but also from their NMR spectra.† The geometrical rigidity and nonplanar structure of the molecular sceleton are characteristic of bicyclic bisureas. Therefore, a chiral environment is created for any pair of geminal protons or N-substituent groups (for example, for CH2 of the ethyl group) to result in diastereotopy displayed in chemical nonequivalence of the above pairs of magnetic nuclei.For compounds 10–12, these are diastereotopic methylene protons of the N-ethyl groups. The 1H NMR spectrum of compound 10 exhibits a singlet of N–Me protons with d 3.03 ppm. The AB system of CH–CH protons exhibits signals with dA 5.23 and dB 5.37 ppm (JAB 8.3 Hz); the former is due to HA located between N-ethyl and N-methyl groups, and the latter, due to the HB proton located between N-ethyl and NH groups because it is additionally split into a doublet with J 2.3 Hz as a result of vicinal spin–spin interaction with the NH proton.According to the structure of compound 10, two N-ethyl groups exhibit the AMX3 and A'M'X'3 systems with the following parameters: dA 3.66, dM 3.33 and dX 1.29 ppm (JAM = 2JAX = 2JMX = 14.0 Hz) and dA' 3.51, dM' 3.31 and dX' 1.25 ppm (JA'M' = 2JA'X' = 2JM'X' = 14.2 Hz), respectively.The signals due to the NH group are represented by a singlet at d 7.18 ppm. The 1H NMR spectrum of compound 11 exhibits two singlets from N–Me groups with the chemical shifts d1 2.89 and d2 2.98 ppm and the AMX3 system with the chemical shifts dA 3.52, dM 3.23 and dX 1.19 ppm and the spin–spin coupling constants JAM = 2JAX = 2JMX = 16.0 Hz.The X-part is a triplet, and the AM-part is a doublet of sextets. The CH–CH protons manifest themselves as the AB system with the very close chemical shifts dA 5.16 and dB 5.17 ppm (JAB 8.2 Hz).The NH group exhibits a singlet at d 7.20 ppm. The 1H NMR spectrum of compound 12 includes the AB system of methine protons with dA 5.28 and dB 5.29 ppm (JAB 8.2 Hz) and a singlet from the NH group with the chemical shift d 7.2 Hz. All ethyl groups in compound 12 are structurally nonequivalent; this fact manifests itself as three AMX3 systems in the spectrum. Two of these systems exhibit similar spectrum charac- † 1H NMR spectra were recorded on a Bruker spectrometer at 250 MHz in CDCl3.Mass spectra were measured on a Varian MAT-311A (EI, 70 eV). Column chromatography was performed using Silica Gel L (100/160 mm) and CHCl3–MeOH (10:1) as an eluent. 9: mp 126–128 °C, Rf 0.26. 1H NMR, d: 2.83 (s, 3H, N–Me), 2.95 (s, 3H, N–Me), 2.99 (s, 3H, N–Me), 5.02 and 5.18 (2H, AB system, CHCH, JAB 8.20 Hz), 7.15 (s, 1H, NH).IR (KBr, n/cm–1): 1700 (C=O), 3320 (NH). MS, m/z: 184 (M+). 10: mp 118–121 °C, Rf 0.34. IR (KBr, n/cm–1): 1685, 1700 (C=O), 3250 (NH). MS, m/z: 212 (M+). 11: mp 148–149 °C, Rf 0.32. IR (KBr, n/cm–1): 1720 (C=O), 3230 (NH). MS, m/z: 198 (M+). 12: mp 130–131 °C, Rf 0.41. IR (KBr, n/cm–1): 1700, 1720 (C=O), 3270 (NH).MS, m/z: 226 (M+). The structures of 9–12 were also confirmed by elemental analysis. 1 R1 = H, R2 = Me 2 R1 = H, R2 = Et 3 R1 = R2 = Me 4 R1 = R2 = Et 5 R3 = R4 = Me 6 R3 = R4 = Et 7 R3 = H, R4 = Me 8 R3 = H, R4 = Et 9 R1 = H, R2 = R3 = R4 = Me 10 R1 = H, R2 = Me, R3 = R4 = Et 11 R1 = H, R2 = Et, R3 = R4 = Me 12 R1 = H, R2 = R3 = R4 = Et 13 R1 = R2 = R3 = R4 = Me 14 R1 = R2 = R3 = R4 = Et N N O R2 R1 N N R3 R4 O NHR1 NHR2 O i, glyoxal N N O R2 R1 OH OH NHR4 NHR3 ii, O 5–8 1–4 9–14 R1, R2 = H, Me, Et Scheme 1 Reagents and conditions: i, H2O, pH 4–5, 45–50 °C, 2 h; ii, H2O, pH 1–2, 90 °C, 1 h.Mendeleev Communications Electronic Version, Issue 1, 2000 (pp. 1–42) teristics as follows: dA = dA' = 3.69, dB = dB' = 3.72 and dX = dX' = = 1.18 ppm (JAM = JA'M' = 2JAX = 2JA'X' = 2JMX = 2JM'X' = 14.4 Hz).The A''M''X'' system has the following parameters: dA'' 3.42, dB'' 3.23 and dX'' 1.14 ppm (JA''M'' = 2JA''X'' = 2JM''X'' = 14.2 Hz). References 1 O. V. Lebedev, L. I. Khmel’nitskii, L. V. Epishina, L. I. Suvorova, I. V. Zaikonnikova, I. E. Zimakova, S. V. Kirshin, A. M. Karpov, V. S. Chudnovskii, M. V. Povstyanoi and V. A. Eres’ko, in Tselenapravlennyi poisk novykh neirotropnykh preparatov (Directed search for novel neurotropic drugs), Zinatne, Riga, 1983, p. 81 (in Russian). 2 I. V. Svitan’ko, I. L. Zyryanov, M. I. Kumskov, L. I. Khmel’nitskii, L. I. Suvorova, A. N. Kravchenko, T. B. Markova, O. V. Lebedev, G. A. Orekhova and S. V. Belova, Mendeleev Commun., 1995, 49. 3 H.Petersen, Liebigs Ann. Chem., 1969, 726, 89. 4 G. A. Orekhova, O. V. Lebedev, Y. A. Strelenko and A. N. Kravchenko, Mendeleev Commun., 1996, 68. 5 H.Petersen, Synthesis, 1973, 243. Received: 8th July 1999; Com. 99/1514

 



返 回